Blue Jet Healthcare Ltd

  • BSE Code : 544009
  • NSE Symbol : BLUEJET
  • ISIN : INE0KBH01020
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 805.10 26.10(3.35%)

Open Price ()

789.90

Prev. Close ()

779.00

Volume (No’s)

553,382

Market Cap ()

13,965.70

Low Price ()

781.85

High Price ()

814.00

 

Board Meetings

Start Date End Date Purpose
31-Jul-2025 31-Jul-2025 Acquisition of land and investment approval
15-Jul-2025 22-Jul-2025 Blue Jet Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/07/2025 inter alia to consider and approve Unaudited financial result along with LRR for the quarter ended June 30 2025 Unaudited Financial Result along with LRR As attached (As per BSE Announcement Dated on 22.07.2025)
09-May-2025 14-May-2025 Blue Jet Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 inter alia to consider and approve Intimation of Board Meeting as per Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 to be held on May 14 2025 Outcome of Board Meeting (As Per BSE Announcement Dated on:14.05.2025)
22-Jan-2025 29-Jan-2025 Blue Jet Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2025 inter alia to consider and approve 1.Approval of the unaudited standalone financial result for the quarter ended December 31 2024 along with Limited Review Report as received from the statutory auditors of the company Unaudited Financial results for the quarter ended 31st December, 2024 Outcome of Board meeting held today ie 29th January, 2025 (As per BSE Announcement Dated on 29/01/2025)
19-Nov-2024 19-Nov-2024 Pursuant to Regulation 30 read with schedule III of SEBI (LODR) Regulation 2015. we wish to inform that the Board of Directors of the Company at the meeting held today, based on the recommendation of the NRC and subject to approval of the shareholders of the Company, have unanimously approved: 1. Reappointment of the following Independent Directors for a period of 5 years: Mr. Girish P Vanvari, Ms. Divya Sameer Momaya, Ms.Preeti G Mehta. 2. Appointment of Independent Director Ms. Priyanka Yadav 3. Appointment of Mr. Popat Kedar as an Executive Director.

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew